Amitriptyline 25mg tablets Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

amitriptyline 25mg tablets

alliance healthcare (distribution) ltd - amitriptyline hydrochloride - oral tablet - 25mg

Amitriptyline 25mg tablets Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

amitriptyline 25mg tablets

phoenix healthcare distribution ltd - amitriptyline hydrochloride - oral tablet - 25mg

SUNLENCA lenacapavir (as sodium) 463.5 mg/1.5 mL solution for injection vial Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

sunlenca lenacapavir (as sodium) 463.5 mg/1.5 ml solution for injection vial

gilead sciences pty ltd - lenacapavir sodium, quantity: 473.1 mg (equivalent: lenacapavir, qty 463.5 mg) - injection, solution - excipient ingredients: macrogol 300; water for injections - sunlenca, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

SUNLENCA lenacapavir (as sodium) 300 mg film coated tablet blister pack Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

sunlenca lenacapavir (as sodium) 300 mg film coated tablet blister pack

gilead sciences pty ltd - lenacapavir sodium, quantity: 306.8 mg (equivalent: lenacapavir, qty 300 mg) - tablet, film coated - excipient ingredients: copovidone; poloxamer; mannitol; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - sunlenca, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.